RVMD
$26.95
Revolution Medicines
($1.83)
(6.36%)
RVMD
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.62)
Revenue:  $10.81 Mil
Wednesday
Nov 10
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RVMD reports earnings?
Beat
Meet
Miss

Where is RVMD's stock price going from here?
Up
Flat
Down
Stock chart of RVMD
Analysts
Summary of analysts' recommendations for RVMD
Score
Grade
Pivots
Resistance
$31.62
$30.62
$28.79

$27.79

Support
$25.95
$24.95
$23.12
Tweet
Growth
Description
Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.